MENU
TSVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
2seventy bio (TSVT) Ownership - Who owns 2seventy bio?
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer... Show more
Profile
Industry
N/A
Address
60 Binney Street
Phone
+1 617 675-7270
Employees
274
Web
https://www.2seventybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
258.81M
P/E Ratio
N/A
Total Cash
192.4M
Projected Growth
N/A
Total Debt
247.45M
Revenue
45.62M
Risk (Beta)
1.58
Dividend Yield
N/A
Total Cash/Share
3.68
Total Debt/Equity
N/A
Revenue/Share
0.73 USD as % of share price
Fundamentals
TSVT
Capitalization
259M
P/E Ratio
N/A
Risk (Beta)
1.58
Dividend Yield
N/A
Total Cash
192M
Total Cash/Share
3.68
Total Debt
247M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.73%
Revenue
45.6M
ROE
N/A
Book Value
228M
P/B Ratio
1.23
Cash Flow
N/A
Earnings
-1.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
4.95
Current Revenue Per Employee
21098.82
Dividends Per Share - Security
N/A
EBITDA
-133.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
57.38
Revenue To Assets
-16.52
Shares Held By Institutions
169M
Shares Outstanding - Current
52.3M
Total Liabilities
276M
Total Volume MTD
N/A
Value
1
Gain YTD
68.367
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
60 Binney Street
Phone
+1 617 675-7270
Employees
274
Web
https://www.2seventybio.com